Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
CALL
Adobe
ADBE
$105B
| $18.4M | 0.01% |
31,500
-19,000
| -38% | -$9.79M |
|
927
Molson Coors Class B
TAP
$8.09B
| $18.4M | 0.01% |
342,334
+35,991
| +12% | +$2.01M |
|
928
SS&C Technologies
SSNC
$18.6B
| $18.3M | 0.01% |
253,935
+104,596
| +70% | +$7.65M |
|
929
Markel Group
MKL
$23.2B
| $18.3M | 0.01% |
15,418
+1,710
| +12% | +$2.05M |
|
930
NovoCure
NVCR
$1.91B
| $18.2M | 0.01% |
82,204
+19,200
| +30% | +$3.73M |
|
931
CALL
Norfolk Southern
NSC
$75.1B
| $18.2M | 0.01% |
68,400
+52,500
| +330% | +$14.5M |
|
932
CALL
Intellia Therapeutics
NTLA
$1.67B
| $18.1M | 0.01% |
112,100
+3,000
| +3% | +$234K |
|
933
Ares Management
ARES
$30.9B
| $18.1M | 0.01% |
285,083
+216,702
| +317% | +$12.1M |
|
934
Nordson
NDSN
$17.3B
| $18.1M | 0.01% |
82,550
+34,343
| +71% | +$7.28M |
|
935
American Financial Group
AFG
$12.1B
| $18.1M | 0.01% |
144,907
+76,344
| +111% | +$9.54M |
|
936
Lamb Weston
LW
$7.19B
| $18.1M | 0.01% |
223,970
-41,703
| -16% | -$3.34M |
|
937
PUT
Chipotle Mexican Grill
CMG
$41.5B
| $18M | 0.01% |
580,000
+235,000
| +68% | +$6.71M |
|
938
Cameco
CCJ
$42.4B
| $17.9M | 0.01% |
935,470
+519,402
| +125% | +$9.8M |
|
939
PUT
SLB Ltd
SLB
$75B
| $17.8M | 0.01% |
+556,400
| New | +$17.1M |
|
940
CALL
General Dynamics
GD
$106B
| $17.8M | 0.01% |
94,600
+44,600
| +89% | +$8.41M |
|
|
BCM
941
DELISTED
iPath Pure Beta Broad Commodity ETN
BCM
| $17.7M | 0.01% |
483,998
| – | – |
|
942
8x8 Inc
EGHT
$332M
| $17.7M | 0.01% |
638,123
+19,364
| +3% | +$549K |
|
943
MKS Inc
MKSI
$20.6B
| $17.6M | 0.01% |
99,124
+39,897
| +67% | +$7.25M |
|
|
FISV
944
PUT
Fiserv Inc
FISV
$27.9B
| $17.6M | 0.01% |
165,000
| – | – |
|
945
Takeda Pharmaceutical
TAK
$55.7B
| $17.6M | 0.01% |
1,047,930
+465,182
| +80% | +$7.92M |
|
946
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
| $17.6M | 0.01% |
+237,443
| New | +$17.8M |
|
947
Blackstone Mortgage Trust
BXMT
$2.38B
| $17.6M | 0.01% |
551,996
+416,139
| +306% | +$13.4M |
|
948
Western Alliance Bancorporation
WAL
$8.87B
| $17.6M | 0.01% |
189,458
+75,536
| +66% | +$7.49M |
|
949
XPO
XPO
$23.7B
| $17.5M | 0.01% |
362,592
+112,362
| +45% | +$5.49M |
|
950
Booz Allen Hamilton
BAH
$9.15B
| $17.5M | 0.01% |
205,687
-51,066
| -20% | -$4.32M |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.